Structures by: Edafe F.
Total: 9
C26H38F6N4OOsP2
C26H38F6N4OOsP2
Inorganica Chimica Acta (2014) 409A, 112-120
a=9.2386(4)Å b=11.0355(5)Å c=15.4940(7)Å
α=103.275(4)° β=97.262(4)° γ=102.771(4)°
C19H26ClF6N2OsP
C19H26ClF6N2OsP
Inorganica Chimica Acta (2014) 409A, 112-120
a=9.2552(11)Å b=9.8786(11)Å c=12.2867(16)Å
α=82.159(15)° β=80.047(14)° γ=84.028(14)°
C20H26ClNOOs
C20H26ClNOOs
Inorganica Chimica Acta (2014) 409A, 112-120
a=12.8543(7)Å b=18.2467(9)Å c=32.5773(15)Å
α=90.00° β=90.00° γ=90.00°
C44H36Au2N3P2,F6P
C44H36Au2N3P2,F6P
Dalton transactions (Cambridge, England : 2003) (2012) 41, 11 3287-3293
a=24.654(4)Å b=11.8666(17)Å c=14.493(2)Å
α=90.00° β=104.051(13)° γ=90.00°
3(C17H30Cl2IrN3P),3(CF3O3S),C2H3N
3(C17H30Cl2IrN3P),3(CF3O3S),C2H3N
Dalton transactions (Cambridge, England : 2003) (2010) 39, 23 5556-5563
a=13.8621(3)Å b=15.8188(4)Å c=18.3948(4)Å
α=102.0414(18)° β=92.5974(18)° γ=90.3916(19)°
3-(1H-benzimidazol-2-yl)-5-bromo-1H-pyrazolo[3,4-b]pyridine dimethyl sulfoxide
C13H8BrN5,C2H6OS
Inorganic Chemistry (2011) 50, 12669-12679
a=8.5399(4)Å b=10.2371(6)Å c=18.5633(11)Å
α=90.00° β=94.712(4)° γ=90.00°
{3-(1H-benzimidazol-kappaN-2-yl)-1H-pyrazolo-kappaN-[3,4-b]pyridine} dichloridobis(dimethyl sulfoxide)ruthenium(II) hydrate
C17H21Cl2N5O2RuS2,H2O
Inorganic Chemistry (2011) 50, 12669-12679
a=7.8726(6)Å b=11.1638(9)Å c=13.0422(10)Å
α=97.546(5)° β=94.461(5)° γ=106.202(5)°
{3-(1H-benzimidazol-kappaN-2-yl)-5-bromo-pyrazolo-kappaN-[3,4-b] pyridin-1-ide}chlorido-tris(dimethyl sufoxide)ruthenium(II) hydrate
C19H25BrClN5O3RuS3,H2O
Inorganic Chemistry (2011) 50, 12669-12679
a=11.8408(9)Å b=12.9306(10)Å c=17.9286(11)Å
α=90.00° β=108.707(4)° γ=90.00°
Dichlorido(dimethyl sulfoxide)(4-formylphenoxyacetyl-hapto^6^-benzylamide) ruthenium(II)
2(C18H21Cl2NO4RuS)O
Inorganic Chemistry (2011) 50, 12669-12679
a=8.5676(4)Å b=10.8811(4)Å c=11.4797(5)Å
α=72.819(2)° β=89.461(3)° γ=77.030(2)°